KR20070011354A - 취약 x염색체 증후군과 같은 strp의 검출 방법 - Google Patents

취약 x염색체 증후군과 같은 strp의 검출 방법 Download PDF

Info

Publication number
KR20070011354A
KR20070011354A KR1020067020635A KR20067020635A KR20070011354A KR 20070011354 A KR20070011354 A KR 20070011354A KR 1020067020635 A KR1020067020635 A KR 1020067020635A KR 20067020635 A KR20067020635 A KR 20067020635A KR 20070011354 A KR20070011354 A KR 20070011354A
Authority
KR
South Korea
Prior art keywords
dna
cgg
nucleic acid
labeled
complementary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020067020635A
Other languages
English (en)
Korean (ko)
Inventor
순갑 한
Original Assignee
바이오셉트 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이오셉트 인코포레이티드 filed Critical 바이오셉트 인코포레이티드
Publication of KR20070011354A publication Critical patent/KR20070011354A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020067020635A 2004-03-01 2005-02-28 취약 x염색체 증후군과 같은 strp의 검출 방법 Withdrawn KR20070011354A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/791,209 2004-03-01
US10/791,209 US20050191636A1 (en) 2004-03-01 2004-03-01 Detection of STRP, such as fragile X syndrome

Publications (1)

Publication Number Publication Date
KR20070011354A true KR20070011354A (ko) 2007-01-24

Family

ID=34887577

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067020635A Withdrawn KR20070011354A (ko) 2004-03-01 2005-02-28 취약 x염색체 증후군과 같은 strp의 검출 방법

Country Status (6)

Country Link
US (1) US20050191636A1 (https=)
EP (1) EP1723261A1 (https=)
JP (1) JP2007525998A (https=)
KR (1) KR20070011354A (https=)
CN (1) CN1926247A (https=)
WO (1) WO2005085476A1 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913697B2 (en) 2001-02-14 2005-07-05 Science & Technology Corporation @ Unm Nanostructured separation and analysis devices for biological membranes
EP2359689B1 (en) 2002-09-27 2015-08-26 The General Hospital Corporation Microfluidic device for cell separation and use thereof
US7468249B2 (en) * 2004-05-05 2008-12-23 Biocept, Inc. Detection of chromosomal disorders
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
EP1857548A1 (en) 2006-05-19 2007-11-21 Academisch Ziekenhuis Leiden Means and method for inducing exon-skipping
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
EP2029779A4 (en) 2006-06-14 2010-01-20 Living Microsystems Inc HIGHLY PARALLEL SNP GENOTYPING UTILIZATION FOR FETAL DIAGNOSIS
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
SI2049664T1 (sl) 2006-08-11 2012-04-30 Prosensa Technologies Bv Enojna veriga oligonukleotidov, komplementarna repetitivnim elementom, za zdravljenje genetskih bolezni, povezanih z nestabilnostjo dnk ponovitev
WO2009008727A2 (en) 2007-07-12 2009-01-15 Prosensa Technologies B.V. Molecules for targeting compounds to various selected organs or tissues
CA2693742A1 (en) 2007-07-12 2009-01-15 Prosensa Technologies B.V. Molecules for targeting compounds to various selected organs, tissues or tumor cells
WO2009045467A1 (en) * 2007-10-02 2009-04-09 Fred Hutchinson Cancer Research Center Methods and compositions for identifying increased risk of developing fragile x-associated disorders
ES2639852T3 (es) 2007-10-26 2017-10-30 Academisch Ziekenhuis Leiden Medios y métodos para contrarrestar los trastornos musculares
USRE48468E1 (en) 2007-10-26 2021-03-16 Biomarin Technologies B.V. Means and methods for counteracting muscle disorders
US8008019B2 (en) * 2007-11-28 2011-08-30 Luminex Molecular Diagnostics Use of dual-tags for the evaluation of genomic variable repeat regions
WO2009099326A1 (en) 2008-02-08 2009-08-13 Prosensa Holding Bv Methods and means for treating dna repeat instability associated genetic disorders
EP2119783A1 (en) 2008-05-14 2009-11-18 Prosensa Technologies B.V. Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associated means
US20090298709A1 (en) * 2008-05-28 2009-12-03 Affymetrix, Inc. Assays for determining telomere length and repeated sequence copy number
CA3069082C (en) 2008-09-20 2022-03-22 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
EP2421971B1 (en) 2009-04-24 2016-07-06 BioMarin Technologies B.V. Oligonucleotide comprising an inosine for treating dmd
CA2767521A1 (en) * 2009-07-10 2011-01-13 Perkinelmer Health Sciences, Inc. Detecting multinucleotide repeats
EP3460074B1 (en) * 2010-02-05 2020-10-07 Quest Diagnostics Investments Incorporated Method to detect repeat sequence motifs in nucleic acid
GB201116131D0 (en) * 2011-09-19 2011-11-02 Epistem Ltd Probe
US20130183666A1 (en) * 2012-01-18 2013-07-18 Marc N. Feiglin Partial genotyping by differential hybridization
NZ627896A (en) 2012-01-27 2016-11-25 Biomarin Technologies B V Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy
CN102703595B (zh) * 2012-06-13 2014-02-12 东南大学 一种碱基选择性可控延伸的str序列高通量检测方法及其检测试剂
CN102952794B (zh) * 2012-09-05 2015-02-25 张家港蓝苏生物工程有限公司 靶向基因dna分子探针的制备方法
CN104531851A (zh) * 2014-12-10 2015-04-22 东南大学 一种基于磁珠与多糖水解分离发光标记物的核酸检测方法
CN104498600A (zh) * 2014-12-10 2015-04-08 东南大学 一种基于磁珠与核酸水解分离发光标记物的核酸检测方法
CN108300776A (zh) * 2017-01-13 2018-07-20 金赟懿 脆性x综合征快速筛查试剂盒
US10459666B2 (en) 2017-03-03 2019-10-29 Commvault Systems, Inc. Using storage managers in respective data storage management systems for license distribution, compliance, and updates
EA202091646A1 (ru) * 2018-01-05 2020-11-17 Квошент Сюисс Са Платформа на основе самособирающегося диагностического массива
GB201803019D0 (en) * 2018-02-26 2018-04-11 Univ Newcastle Methods for detecting target polynucleotides

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2094938A1 (en) * 1991-01-04 1992-07-05 Grant R. Sutherland Dna sequences related to isolated fragile x syndrome
US6180337B1 (en) * 1991-05-24 2001-01-30 Baylor College Of Medicine Diagnosis of the fragile X syndrome
US6200747B1 (en) * 1992-01-28 2001-03-13 North Shore University Hospital Research Corp. Method and kits for detection of fragile X specific, GC-rich DNA sequences
WO1994003638A1 (en) * 1992-07-30 1994-02-17 Applied Biosystems, Inc. Method of detecting aneuploidy by amplified short tandem repeats
JP2807612B2 (ja) * 1993-03-12 1998-10-08 ノボ ノルディスク アクティーゼルスカブ 新規キシラナーゼ、その製造法、該キシラナーゼによるパルプ処理方法及びキシロオリゴ糖の製造法
US6120992A (en) * 1993-11-04 2000-09-19 Valigene Corporation Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, and allele identification in a diseased human
US5753439A (en) * 1995-05-19 1998-05-19 Trustees Of Boston University Nucleic acid detection methods
US5888740A (en) * 1997-09-19 1999-03-30 Genaco Biomedical Products, Inc. Detection of aneuploidy and gene deletion by PCR-based gene- dose co-amplification of chromosome specific sequences with synthetic sequences with synthetic internal controls
US6143504A (en) * 1998-10-27 2000-11-07 Arch Development Corporation Methods and compositions for the diagnosis of fragile X syndrome
US6268147B1 (en) * 1998-11-02 2001-07-31 Kenneth Loren Beattie Nucleic acid analysis using sequence-targeted tandem hybridization
US6225061B1 (en) * 1999-03-10 2001-05-01 Sequenom, Inc. Systems and methods for performing reactions in an unsealed environment
US6638719B1 (en) * 1999-07-14 2003-10-28 Affymetrix, Inc. Genotyping biallelic markers
US20040265883A1 (en) * 2003-06-27 2004-12-30 Biocept, Inc. mRNA expression analysis

Also Published As

Publication number Publication date
JP2007525998A (ja) 2007-09-13
CN1926247A (zh) 2007-03-07
EP1723261A1 (en) 2006-11-22
WO2005085476A1 (en) 2005-09-15
US20050191636A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
KR20070011354A (ko) 취약 x염색체 증후군과 같은 strp의 검출 방법
US20240368682A1 (en) Systems and methods for clonal replication and amplification of nucleic acid molecules for genomic and therapeutic applications
KR101176091B1 (ko) 염색체 이상의 검출방법
EP1241266A1 (en) Method of detecting nucleotide polymorphism
US20030148301A1 (en) Method of detecting nucleotide polymorphism
JP6234463B2 (ja) 核酸の多重分析の方法
JPWO2001042498A1 (ja) 塩基多型の検出方法
KR20020008195A (ko) 폴리뉴클레오티드 서열 변형의 미세배열-기초 분석
JP5663491B2 (ja) 標的核酸の検出方法
KR101573467B1 (ko) 방광암 특이적 후성유전적 마커 유전자를 이용한 방광암의 검출방법
JP2002017399A (ja) 塩基多型を検出する方法
EP1207209A2 (en) Methods using arrays for detection of single nucleotide polymorphisms
US20040038258A1 (en) Methods for detecting DNA polymorphisms
JP2002209584A (ja) 塩基多型を検出する方法
JP2001095574A (ja) 塩基多型を検出する方法
JP5017947B2 (ja) 複数の塩基多型の同定方法
JP2002034598A (ja) 塩基多型を検出する方法
JP2010246400A (ja) 多型の識別方法
HK1106553A (en) Detection of chromosomal disorders
HK1102059A (en) Detection of strp, such as fragile x syndrome
JP2007006863A (ja) チトクロームp4502c9遺伝多型の検出方法
KR20100084760A (ko) PLCG1 및 RasGRP3 유전자로부터 유래된 단일염기다형을 포함하는 폴리뉴클레오티드, 이를 포함하는마이크로어레이 및 진단키트, 및 이를 이용한 분석방법
HK1232917B (en) Methods for clonal replication and amplification of nucleic acid molecules for genomic and therapeutic applications
JP2003135069A (ja) 塩基多型の同定方法
WO2010126836A1 (en) Method of prenatal molecular diagnosis of down syndrome and other trisomic disorders

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20061002

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid